3.67 USD
↗ 0.22 (6.38%)AT CLOSE (11:59 AM EDT)
NRX Pharmaceuticals, Inc. Common Stock
NRXPNASDAQ • USD
3.67
↘ 0.00 (0.11%)
POST MARKET (AS OF 07:45 PM EDT)
Post Market
AS OF 07:45 PM EDT
3.67
↘ 0.00 (0.11%)
Market: OPEN
NRX Pharmaceuticals, Inc. Common Stock (NRXP) is currently trading at $3.67. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (13811.8%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 25, 2026.
Open?$3.49
High?$3.69
Low?$3.43
Prev. Close?$3.45
Volume?890.6K
Avg. Volume?1.1M
VWAP?$3.58
Rel. Volume?0.81x
Bid / Ask
Bid?$3.13 × 100
Ask?$4.21 × 100
Spread?$1.08
Midpoint?$3.67
Valuation & Ratios
Market Cap?149.4M
Shares Out?43.3M
Float?31.0M
Float %?85.6%
P/E Ratio?N/A
P/B Ratio?-878.65
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Address
1201 ORANGE STREET
WILMINGTON, DE 19801
Phone: 484-254-6134
WILMINGTON, DE 19801
Phone: 484-254-6134
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?60
Short Sent.?13
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.69Distress
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?27.97%Squeeze Risk
Short Interest?8.7M
Days to Cover?5.8
Free Float31.0M
Avg Daily Volume1.5M
Settlement Date2026-08-14
Financial Health
Current Ratio?0.86Weak
Quick Ratio?0.86Weak
Cash Ratio?0.79Adequate
Debt/Equity?-2.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-878.65CHEAP▾
S&P97
P/S?44.01HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-6.2CHEAP▾
S&P97
EV/Sales?36.27HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?13,811.8%STRONG▾
Peers50
S&P97
ROA?-68.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-20671000
Enterprise Value?$123.1M
Fundamentals ratios updated end of day